MDR1 single nucleotide polymorphisms: Multiplicity of haplotypes and functional consequences

Pharmacogenetics

Volumn 12, Issue 6, 2002, Pages 425-427

  Kim, Richard B ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CYCLOSPORIN; DIGOXIN; FEXOFENADINE; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 1; NELFINAVIR; TACROLIMUS;

GENE EXPRESSION; GENE FUNCTION; GENETIC CODE; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; SHORT SURVEY; SINGLE NUCLEOTIDE POLYMORPHISM; ETHNIC GROUP; GENE; GENE LINKAGE DISEQUILIBRIUM; GENETICS; NOTE;

ETHNIC GROUPS; GENES, MDR; GENOTYPE; HAPLOTYPES; HUMAN; LINKAGE DISEQUILIBRIUM; POLYMORPHISM, SINGLE NUCLEOTIDE; HUMANS;

EID: 0036667955     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-200208000-00002     Document Type: Short Survey

References (17)

1. Drugs as P-glycoprotein substrates, inhibitors, and inducers
2. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs
3. Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations
4. C3435T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3A4 rather than Pgp in recipients of living-donor liver transplantation
5. Identification of functionally variant MDR1 alleles among European Americans and African Americans
6. Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo
7. MDR1 genotype-related pharmacokinetics of digoxin after single oral administration in healthy Japanese subjects
8. MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine
9. Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: A pharmacogenetics study
10. C3435T Mutation in exon 26 of the human MDR1 gene and cyclosporine pharmacokinetics in healthy subjects
11. The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells
12. No influence of the MDR-1 C3435T polymorphism or a CYP3A4 promoter polymorphism (CYP3A4-V allele) on dose-adjusted cyclosporin A trough concentrations or rejection incidence in stable renal transplant recipients
13. Expression of P-glycoprotein in human placenta: Relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene
14. Functional characterization of coding polymorphisms in the human MDR1 gene using a vaccinia virus expression system
15. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
16. Identification of a P-glycoprotein-deficient subpopulation in the CF-1 mouse strain using a restriction fragment length polymorphism
17. Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene